Financial Ratios

SAMRAT PHARMACHEM LTD.

NSE : NABSE : 530125ISIN CODE : INE103E01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE366.251.15 (+0.31 %)
PREV CLOSE ( ) 365.10
OPEN PRICE ( ) 355.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2377
TODAY'S LOW / HIGH ( )353.40 374.60
52 WK LOW / HIGH ( ) 320604.3
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)53.8355.6217.2613.714.97
   CEPS(Rs)55.9157.5418.8615.096.32
   DPS(Rs)1.001.000.000.000.00
   Book NAV/Share(Rs)204.37151.5495.9278.6664.95
   Tax Rate(%)26.1927.1927.3826.7628.83
Margin Ratios
   Core EBITDA Margin(%)7.7010.934.244.222.53
   EBIT Margin(%)7.6510.954.224.302.57
   Pre Tax Margin(%)7.2510.643.593.681.72
   PAT Margin (%)5.357.752.612.701.22
   Cash Profit Margin (%)5.568.022.852.971.56
Performance Ratios
   ROA(%)16.5724.209.228.603.79
   ROE(%)30.2544.9519.7719.107.96
   ROCE(%)34.9152.3323.9022.4311.80
   Asset Turnover(x)3.093.123.533.193.09
   Sales/Fixed Asset(x)19.9515.3516.0714.0611.64
   Working Capital/Sales(x)6.776.5410.229.969.33
Efficiency Ratios
   Fixed Capital/Sales(x)0.050.070.060.070.09
   Receivable days55.7063.0254.3156.7562.50
   Inventory Days26.4019.6026.9431.0121.51
   Payable days36.3039.4545.3452.0141.00
Valuation Parameters
   PER(x)6.898.727.884.3715.02
   PCE(x)6.648.427.213.9711.81
   Price/Book(x)1.823.201.420.761.15
   Yield(%)0.270.210.000.000.00
   EV/Net Sales(x)0.390.640.270.190.25
   EV/Core EBITDA(x)4.985.735.293.717.53
   EV/EBIT(x)5.115.875.603.958.50
   EV/CE(x)1.051.690.840.460.68
   M Cap / Sales0.370.680.230.130.21
Growth Ratio
   Net Sales Growth(%)40.0923.8730.2423.6819.58
   Core EBITDA Growth(%)-1.87172.3626.7998.19-41.35
   EBIT Growth(%)-2.11181.6027.46110.30-44.39
   PAT Growth(%)-3.23222.2225.88175.91-52.26
   EPS Growth(%)-3.23222.2225.88175.91-52.26
Financial Stability Ratios
   Total Debt/Equity(x)0.300.160.300.390.33
   Current Ratio(x)1.871.911.731.471.69
   Quick Ratio(x)1.251.581.310.911.28
   Interest Cover(x)19.2935.996.756.913.04
   Total Debt/Mcap(x)0.160.050.210.510.28

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.